198 related articles for article (PubMed ID: 34609480)
1. Low-molecular-weight heparin use in coronavirus disease 2019 is associated with curtailed viral persistence: a retrospective multicentre observational study.
Pereyra D; Heber S; Schrottmaier WC; Santol J; Pirabe A; Schmuckenschlager A; Kammerer K; Ammon D; Sorz T; Fritsch F; Hayden H; Pawelka E; Krüger P; Rumpf B; Traugott MT; Glaser P; Firbas C; Schörgenhofer C; Seitz T; Karolyi M; Pabinger I; Brostjan C; Starlinger P; Weiss G; Bellmann-Weiler R; Salzer HJF; Jilma B; Zoufaly A; Assinger A
Cardiovasc Res; 2021 Dec; 117(14):2807-2820. PubMed ID: 34609480
[TBL] [Abstract][Full Text] [Related]
2. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
3. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
[TBL] [Abstract][Full Text] [Related]
4. Edoxaban Versus Low-Molecular-Weight Heparin in Hospitalized COVID-19 Patients With Atrial Fibrillation.
Olivera P; Velásquez-Escandón C; Campoy D; Flores K; Canals T; Johansson E; Herranz MJ; Martínez L; Cerezo-Manchado JJ; Salinas R
Clin Appl Thromb Hemost; 2023; 29():10760296231180865. PubMed ID: 37282505
[TBL] [Abstract][Full Text] [Related]
5. The Association of Low Molecular Weight Heparin Use and In-hospital Mortality Among Patients Hospitalized with COVID-19.
Shen L; Qiu L; Liu D; Wang L; Huang H; Ge H; Xiao Y; Liu Y; Jin J; Liu X; Wang DW; Peterson ED; He B; Zhou N
Cardiovasc Drugs Ther; 2022 Feb; 36(1):113-120. PubMed ID: 33394360
[TBL] [Abstract][Full Text] [Related]
6. Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study.
Di Castelnuovo A; Costanzo S; Antinori A; Berselli N; Blandi L; Bonaccio M; Cauda R; Guaraldi G; Menicanti L; Mennuni M; Parruti G; Patti G; Santilli F; Signorelli C; Vergori A; Abete P; Ageno W; Agodi A; Agostoni P; Aiello L; Al Moghazi S; Arboretti R; Astuto M; Aucella F; Barbieri G; Bartoloni A; Bonfanti P; Cacciatore F; Caiano L; Carrozzi L; Cascio A; Ciccullo A; Cingolani A; Cipollone F; Colomba C; Colombo C; Crosta F; Danzi GB; D'Ardes D; de Gaetano Donati K; Di Gennaro F; Di Tano G; D'Offizi G; Fantoni M; Fusco FM; Gentile I; Gianfagna F; Grandone E; Graziani E; Grisafi L; Guarnieri G; Larizza G; Leone A; Maccagni G; Madaro F; Maitan S; Mancarella S; Mapelli M; Maragna R; Marcucci R; Maresca G; Marongiu S; Marotta C; Marra L; Mastroianni F; Mazzitelli M; Mengozzi A; Menichetti F; Meschiari M; Milic J; Minutolo F; Molena B; Montineri A; Mussini C; Musso M; Niola D; Odone A; Olivieri M; Palimodde A; Parisi R; Pasi E; Pesavento R; Petri F; Pinchera B; Poletti V; Ravaglia C; Rognoni A; Rossato M; Rossi M; Sangiovanni V; Sanrocco C; Scorzolini L; Sgariglia R; Simeone PG; Taddei E; Torti C; Vettor R; Vianello A; Vinceti M; Virano A; Vocciante L; De Caterina R; Iacoviello L
Thromb Haemost; 2021 Aug; 121(8):1054-1065. PubMed ID: 33412596
[TBL] [Abstract][Full Text] [Related]
7. Impact of proactive low-molecular weight heparin therapy on outcomes in COVID-1.
Gormez S; Gumusel HK; Ekicibasi E; Degirmencioglu A; Paudel A; Akan G; Atalar F; Erdim R; Eroglu E; Dagdelen S; Sariguzel N; Kirisoglu CE; Pamukcu B
Bratisl Lek Listy; 2021; 122(8):582-589. PubMed ID: 34282625
[TBL] [Abstract][Full Text] [Related]
8. Low molecular weight heparin is useful in adult COVID-19 inpatients. Experience during the first Spanish wave: observational study.
Gonzalez-Porras JR; Belhassen-Garcia M; Lopez-Bernus A; Vaquero-Roncero LM; Rodriguez B; Carbonell C; Azibeiro R; Hernandez-Sanchez A; Martin-Gonzalez JI; Manrique JM; Alonso-Claudio G; Alvarez-Navia F; Madruga-Martin JI; Macias-Casanova RP; García-Criado J; Lozano F; Moyano JC; Sanchez-Hernandez MV; Sagredo-Meneses V; Borras R; Bastida JM; Hernández-Pérez G; Chamorro AJ; Marcos M; Martin-Oterino JA
Sao Paulo Med J; 2022; 140(1):123-133. PubMed ID: 34406312
[TBL] [Abstract][Full Text] [Related]
9. The effectiveness of early anticoagulant treatment in Covid-19 patients.
Arslan Y; Yilmaz G; Dogan D; Hasirci M; Cetindogan H; Ocal N; Savasci U; Fidan G; Tasci C
Phlebology; 2021 Jun; 36(5):384-391. PubMed ID: 33243082
[TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy of atrial fibrillation in COVID-19 patients.
Tomaszuk-Kazberuk A; Koziński M; Domienik-Karłowicz J; Jaguszewski M; Darocha S; Wybraniec M; Dobrowolski P; Kupczyńska K; Michalski B; Wańha W; Kapłon-Cieślicka A
Cardiol J; 2021; 28(5):758-766. PubMed ID: 34382204
[TBL] [Abstract][Full Text] [Related]
11. Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients.
DE Vito A; Saderi L; Fiore V; Geremia N; Princic E; Fanelli C; Muredda AA; Panu Napodano C; Moi G; Maida I; Fois AG; Sotgiu G; Madeddu G; Babudieri S
Panminerva Med; 2023 Sep; 65(3):286-291. PubMed ID: 35622392
[TBL] [Abstract][Full Text] [Related]
12. Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial.
Busani S; Tosi M; Mighali P; Vandelli P; D'Amico R; Marietta M; Forfori F; Donati A; Cinnella G; De Monte A; Pasero D; Bellani G; Tascini C; Foti G; Ranieri M; Girardis M
Trials; 2020 Aug; 21(1):724. PubMed ID: 32807241
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
[TBL] [Abstract][Full Text] [Related]
14. Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients.
Volteas P; Drakos P; Alkadaa LN; Cleri NA; Asencio AA; Oganov A; Giannopoulos S; Saadon JR; Mikell CB; Rubano JA; Labropoulos N; Tassiopoulos AK; Mofakham S; Bannazadeh M
J Vasc Surg Venous Lymphat Disord; 2022 Sep; 10(5):1128-1136. PubMed ID: 35716998
[TBL] [Abstract][Full Text] [Related]
15. Early low-molecular-weight heparin administration is associated with shorter time to SARS-CoV-2 swab negativity.
Trunfio M; Salvador E; Gaviraghi A; Audagnotto S; Marinaro L; Motta I; Casciaro R; Ghisetti V; Fava C; Bonora S; Di Perri G; Calcagno A;
Antivir Ther; 2020; 25(6):327-333. PubMed ID: 33506810
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
; ; ; Lawler PR; Goligher EC; Berger JS; Neal MD; McVerry BJ; Nicolau JC; Gong MN; Carrier M; Rosenson RS; Reynolds HR; Turgeon AF; Escobedo J; Huang DT; Bradbury CA; Houston BL; Kornblith LZ; Kumar A; Kahn SR; Cushman M; McQuilten Z; Slutsky AS; Kim KS; Gordon AC; Kirwan BA; Brooks MM; Higgins AM; Lewis RJ; Lorenzi E; Berry SM; Berry LR; Aday AW; Al-Beidh F; Annane D; Arabi YM; Aryal D; Baumann Kreuziger L; Beane A; Bhimani Z; Bihari S; Billett HH; Bond L; Bonten M; Brunkhorst F; Buxton M; Buzgau A; Castellucci LA; Chekuri S; Chen JT; Cheng AC; Chkhikvadze T; Coiffard B; Costantini TW; de Brouwer S; Derde LPG; Detry MA; Duggal A; Džavík V; Effron MB; Estcourt LJ; Everett BM; Fergusson DA; Fitzgerald M; Fowler RA; Galanaud JP; Galen BT; Gandotra S; García-Madrona S; Girard TD; Godoy LC; Goodman AL; Goossens H; Green C; Greenstein YY; Gross PL; Hamburg NM; Haniffa R; Hanna G; Hanna N; Hegde SM; Hendrickson CM; Hite RD; Hindenburg AA; Hope AA; Horowitz JM; Horvat CM; Hudock K; Hunt BJ; Husain M; Hyzy RC; Iyer VN; Jacobson JR; Jayakumar D; Keller NM; Khan A; Kim Y; Kindzelski AL; King AJ; Knudson MM; Kornblith AE; Krishnan V; Kutcher ME; Laffan MA; Lamontagne F; Le Gal G; Leeper CM; Leifer ES; Lim G; Lima FG; Linstrum K; Litton E; Lopez-Sendon J; Lopez-Sendon Moreno JL; Lother SA; Malhotra S; Marcos M; Saud Marinez A; Marshall JC; Marten N; Matthay MA; McAuley DF; McDonald EG; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Moore SC; Morillo Guerrero R; Mouncey PR; Murthy S; Nair GB; Nair R; Nichol AD; Nunez-Garcia B; Pandey A; Park PK; Parke RL; Parker JC; Parnia S; Paul JD; Pérez González YS; Pompilio M; Prekker ME; Quigley JG; Rost NS; Rowan K; Santos FO; Santos M; Olombrada Santos M; Satterwhite L; Saunders CT; Schutgens REG; Seymour CW; Siegal DM; Silva DG; Shankar-Hari M; Sheehan JP; Singhal AB; Solvason D; Stanworth SJ; Tritschler T; Turner AM; van Bentum-Puijk W; van de Veerdonk FL; van Diepen S; Vazquez-Grande G; Wahid L; Wareham V; Wells BJ; Widmer RJ; Wilson JG; Yuriditsky E; Zampieri FG; Angus DC; McArthur CJ; Webb SA; Farkouh ME; Hochman JS; Zarychanski R
N Engl J Med; 2021 Aug; 385(9):790-802. PubMed ID: 34351721
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of low molecular weight heparin is reduced in COVID-19.
Watson O; Zaldua JC; Pillai S; Whitley J; Howard M; Lawrence M; Hawkins K; Morris K; Evans PA
Clin Hemorheol Microcirc; 2023; 84(3):333-344. PubMed ID: 36442189
[TBL] [Abstract][Full Text] [Related]
18. The Potential of Low Molecular Weight Heparin to Mitigate Cytokine Storm in Severe COVID-19 Patients: A Retrospective Cohort Study.
Shi C; Wang C; Wang H; Yang C; Cai F; Zeng F; Cheng F; Liu Y; Zhou T; Deng B; Vlodavsky I; Li JP; Zhang Y
Clin Transl Sci; 2020 Nov; 13(6):1087-1095. PubMed ID: 32881340
[TBL] [Abstract][Full Text] [Related]
19. Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
Samajdar SS; Sam PA; Moitra S; Ray Y; Pal J; Joshi SR; Tripathi SK
J Assoc Physicians India; 2020 Sep; 68(9):52-61. PubMed ID: 32798346
[TBL] [Abstract][Full Text] [Related]
20. Use of low-molecular weight heparin, transfusion and mortality in COVID-19 patients not requiring ventilation.
Grandone E; Tiscia G; Pesavento R; De Laurenzo A; Ceccato D; Sartori MT; Mirabella L; Cinnella G; Mastroianno M; Dalfino L; Colaizzo D; Vettor R; Intrieri M; Ostuni A; Margaglione M;
J Thromb Thrombolysis; 2021 Oct; 52(3):772-778. PubMed ID: 33844150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
